Sable Therapeutics
Pre-clinicalDevelops small molecule therapeutics targeting protein degradation pathways for oncology and inflammatory diseases.
Founded
2020
Focus
Nanotechnology
About
Develops small molecule therapeutics targeting protein degradation pathways for oncology and inflammatory diseases.
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile